2m 2m 2m 2m 2m 2m 2m
Liminatus-A (LIMN)
NASDAQ
$5.38+$0.21 (+4.17%)
Price as of Aug 21, 2026 7:54 PM EDT- $346.5MMarket Cap
- -96.97%1-Year Change
- BiotechnologyIndustry
Liminatus-A (LIMN)
$5.38+$0.21 (+4.17%)
LIMN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.16 | ||
Change | -$0.47 (-8.35%) | ||
Open | $5.53 | ||
High | $5.88 | ||
Low | $5.15 | ||
Previous Close | $0.11 | ||
Volume | 117,361 | ||
30-Day Average Volume | 575,310 | ||
1-Week Change | -26.29% | ||
1-Month Change | -13.78% | ||
1-Year Change | -96.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.2M | ||
Total Assets | $3.4M | ||
Market Cap | $346.5M | ||
Enterprise Value | $345.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$969,999.00 | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | $352,044.00 | ||
EPS | -$1.50 | ||
Enterprise Value/EBITDA | -245 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1,153 | ||
P/E | -3 | ||
PEG | N/A | ||
Price/Free Cash Flow | -357 | ||
Price/Operating Cash Flow | -357 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 08/21/2026 | ||
Earnings & Revenue